Signos raised $20 million to expand its glucose monitoring platform for weight loss, which pairs Dexcom’s over-the-counter ...

CGMs can help people avoid serious diabetes complications, save money through better management and adjust behavior based on ...

Continuous glucose monitors are wearable devices that track your blood glucose levels 24 hours a day and provide real-time data on trends. CGMs use a sensor inserted into the skin and a transmitter to ...

Credit: Signos. The Signos Glucose Monitoring System is a mobile device application that receives data from an OTC integrated continuous glucose monitor, the Dexcom Stelo Biosenor. The app translates ...

Signos Inc. landed U.S. FDA clearance for its over-the-counter glucose monitoring system, which combines Dexcom Inc.'s non-prescription Stelo continuous glucose monitor with an AI-powered platform ...

GV (Google Ventures), Dexcom, and Blue Cross Blue Shield of Alabama co-invest; Dexcom to distribute Signos for sustainable weight management Signos Inc., the company behind the first FDA-cleared, over ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Kelly ...

A continuous glucose monitor, or CGM, is a wearable device that tracks glucose around the clock instead of capturing a single ...

The app translates glucose fluctuations into personalized recommendations, providing users with the tools they need to make impactful changes. Signos Inc. has announced the availability of the Signos ...

Signos Inc., the company behind the first FDA-cleared, over-the-counter glucose monitoring system for weight management, today announced a $20 million funding round with investment from GV (Google ...